Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TD Tele-Doc Weight Loss vs Zeuss

TD Tele-Doc Weight Loss
Graded #286

Lower grade

vs+7.400000000000006
Zeuss
Graded #132

Higher grade

The verdict

Zeuss takes it — 69.2/100 to 61.8/100.

Zeuss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Zeuss is a multi-vertical telehealth platform offering compounded semaglutide and tirzepatide for weight loss alongside TRT, HRT, skin, and hair services.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueZeuss +40
45
85
Dose & formulationZeuss +11
53
64
Clinical oversightTD Tele-Doc Weight Loss +16
88
72
Labs & monitoringTD Tele-Doc Weight Loss +13
65
52
FulfillmentTD Tele-Doc Weight Loss +1
68
67
Contract termsZeuss +6
55
61
TD Tele-Doc Weight Loss · left barZeuss · right bar

The numbers

MetricTD Tele-Doc Weight LossZeuss
WeighScore61.8/10069.2/100
GradeCC
Scorecard rank#286#132
SemaglutideNot disclosed$125/mo (compounded)
TirzepatideNot disclosed$175/mo (compounded)
Coverage2 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
TD Tele-Doc Weight Loss

Graded #286 · C

Strengths

  • Brand Wegovy/Zepbound AND compounded sema available; prescribing based on medical history and coverage
  • 100% virtual — weekly appointments with board-certified MDs from home; no travel required
  • Remote Patient Monitoring Starter Box: biometric scale + blood pressure cuff sync to care team in real time
  • In-network with most commercial insurance plans; may cover visits and monitoring equipment
  • Physician-led by Dr. Peter Wilbanks MD (30-yr OB/GYN, VCU) and Dr. Michael Perini MD (ABIM board-certified)

Where it loses points

  • No public cash pricing; cost entirely depends on insurance coverage — not viable for uninsured patients
  • Telehealth available only in Virginia and Maryland; no national reach confirmed
  • No Medicare or Medicaid accepted; limited to commercial insurance plans only
  • No LegitScript certification found; compounded availability and specific pricing undisclosed on site
  • Tirzepatide (Zepbound/Mounjaro) availability less prominent in MD pages; semaglutide is primary focus
Zeuss

Graded #132 · C

Strengths

  • One-time-purchase model with no subscription — genuinely rare among DTC GLP-1 providers
  • Publishes the FDA compounded-medication disclaimer
  • Names both 503A and 503B compounding pathways — uncommon transparency
  • Bundled pricing covers provider review, meds, and cold-chain shipping with no hidden fees
  • Full refund if a physician can't prescribe

Where it loses points

  • 503A pharmacy partner not named (only generic '503A and 503B state-licensed' framing)
  • LegitScript certification not mentioned
  • No named medical director or physician leadership
  • Full states-served list not disclosed
  • Corporate legal entity not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard